+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Latin America Ophthalmology Drugs and Devices Market 2019-2027

  • ID: 4827830
  • Report
  • Region: Latin America
  • 92 pages
  • Triton Market Research
UP TO OFF
until Jan 31st 2020
1 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
Market Outlook

The ophthalmology drugs and devices market in Latin America has been projected to burgeon with a CAGR of 6.89% during the forecast years 2019-2027, according to a report by the author. Brazil, Mexico and countries in rest of Latin America together form the market for ophthalmology drugs and devices in the Latin American region. Risks associated with the treatment of ocular diseases are creating challenges for the growth of the ophthalmology drugs and devices market. For instance, different surgeries for the treatment of eye disorders such as cataract surgery, glaucoma surgery and vitreoretinal surgery have complications associated with them. As per the Mayo Clinic organization, in cataract surgery, there are some complications such as infection, inflammation, swelling, bleeding, dislocation of the artificial lens, drooping eyelid, glaucoma, retinal detachment, loss of vision and secondary cataract. In addition to this, the risk of complication is more in a person if one has another ophthalmic disease or a serious medical condition. On the other hand, risks associated with glaucoma surgery include vision loss, bleeding inside the eye, infection inside the eye and low eye pressure. Further, vitrectomy surgeries may have complications associated with the surgery, such as cataracts, raised pressure inside the eye, more bleeding in vitreous, retinal detachment, damage to the eye’s lens and more. Thus, various risks and complications associated with the treatment of ocular diseases are creating a challenge for the growth of the ophthalmology drugs and devices market.

Competitive Outlook
The notable players in the market are Allergan, Inc., Carl Zeiss AG, GlaxoSmithKline, Novartis International AG and Roche Holding AG.
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • MORE
1. Latin America Ophthalmology Drugs and Devices Market - Summary

2. Industry Outlook
2.1. Market Definition
2.2. Porter's Five Forces Analysis
2.2.1. Bargaining Power of Buyers
2.2.2. Bargaining Power of Supplier
2.2.3. Threats of New Entrants
2.2.4. Threats of Substitutes
2.2.5. Competitive Rivalry
2.3. Strategic Outlook
2.4. Key Insight
2.5. Value Chain Outlook
2.6. Key Buying Standards
2.7. Investment Outlook
2.8. Supply Chain Outlook
2.9. Market Drivers
2.9.1. Increasing Ophthalmic Disorders Due to High Blood Sugar
2.9.2. Upsurge in Healthcare Spending
2.9.3. Technological Advancement
2.10. Market Restraints
2.10.1. Expirations of Brand Patents Have Affected the Pharmaceutical Industry
2.10.2. Low Cognizance Related to Ophthalmic Drugs
2.10.3. Drug Approvals Delay and Number of Drugs in the Pipeline
2.11. Market Opportunities
2.11.1. Demand for Phacoemulsification Devices and Intraocular Lenses Is Increasing
2.12. Market Challenges
2.12.1. Difficulties Associated With the Conduct of Ocular Diseases

3. Ophthalmology Drugs and Devices Market Outlook - by Drugs and Devices
3.1. Devices
3.1.1. Diagnostic & Monitoring Equipment
3.1.1.1. Optical Coherence Tomography
3.1.1.2. Ophthalmic Ultrasound Imaging Systems
3.1.1.3. Fundus Camera Market
3.1.1.4. Ophthalmoscopes
3.1.1.5. Retinoscope
3.1.1.6. Pachymeter
3.1.1.7. Wavefront Aberrometers
3.1.1.8. Perimeters/Visual Field Analyzer
3.1.1.9. Autorefractors/Phoropter
3.1.1.10. Specular Microscope
3.1.1.11. Corneal Topographers
3.1.1.12. Other Diagnostic & Monitoring Equipment Market
3.1.2. Surgery Devices
3.1.2.1. Cataract Surgery Devices
3.1.2.2. Glaucoma Surgery Devices
3.1.2.3. Refractive Surgery Devices
3.1.2.4. Vitreoretinal Surgery Devices
3.2. Vision Care
3.3. Drugs
3.3.1. Glaucoma Drug
3.3.2. Retinal Disorder Drug
3.3.3. Dry Eye Drug
3.3.4. Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug
3.3.5. Drugs by Use of Preservation
3.3.5.1. Preserved Drugs
3.3.5.2. Preservative Free Drugs

4. Ophthalmology Drugs and Devices Market - Regional Outlook
4.1.1. Brazil
4.1.2. Mexico
4.1.3. Rest of Latin America

5. Competitive Landscape
5.1. Allergan, Inc.
5.2. Bayer
5.3. Carl Zeiss AG
5.4. Essilor International S.A.
5.5. Glaxosmithkline
5.6. Johnson & Johnson, Inc.
5.7. Novartis International AG
5.8. Pfizer
5.9. Roche Holding AG
5.10. Santen Pharmaceutical Co., Ltd.

6. Methodology and Scope
6.1. Research Scope
6.2. Sources of Data
6.3. Research Methodology

List of Tables
Table 1 Latin America Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Table 2 Common Causes of Loss of Vision in the Elderly
Table 3 Selected Lists of Glaucoma Drugs in Late-Stage Clinical Trials
Table 4 Latin America Ophthalmology Drugs and Devices Market by Drugs and Devices 2019-2027 ($ Million)
Table 5 Latin America Devices Market in Diagnostic & Monitoring Equipment by Types 2019-2027 ($ Million)
Table 6 Latin America Devices Market in Surgery Device by Types 2019-2027 ($ Million)
Table 7 Latin America Drugs and Devices Market in Drugs by Types 2019-2027 ($ Million)
Table 8 Latin America Ophthalmology Drugs and Devices Market by Countries 2019-2027 ($ Million)

List of Figures
Figure 1 Latin America Ophthalmology Drugs and Devices Market 2019-2027
Figure 2 Latin America Drugs and Devices Market in Devices 2019-2027 ($ Million)
Figure 3 Latin America Devices Market in Diagnostic & Monitoring Equipment 2019-2027 ($ Million)
Figure 4 Latin America Diagnostic & Monitoring Equipment Market in Optical Coherence Tomography 2019-2027 ($ Million)
Figure 5 Latin America Diagnostic & Monitoring Equipment Market in Ophthalmic Ultrasound Imaging Systems 2019-2027 ($ Million)
Figure 6 Latin America Diagnostic & Monitoring Equipment Market in Fundus Camera Market 2019-2027 ($ Million)
Figure 7 Latin America Diagnostic & Monitoring Equipment Market in Ophthalmoscopes 2019-2027 ($ Million)
Figure 8 Latin America Diagnostic & Monitoring Equipment Market in Retinoscope 2019-2027 ($ Million)
Figure 9 Latin America Diagnostic & Monitoring Equipment Market in Pachymeter 2019-2027 ($ Million)
Figure 10 Latin America Diagnostic & Monitoring Equipment Market in Wavefront Aberrometers 2019-2027 ($ Million)
Figure 11 Latin America Diagnostic & Monitoring Equipment Market in Perimeters/Visual Field Analyzer 2019-2027 ($ Million)
Figure 12 Latin America Diagnostic & Monitoring Equipment Market in Autorefractors/Phoropter 2019-2027 ($ Million)
Figure 13 Latin America Diagnostic & Monitoring Equipment Market in Specular Microscope 2019-2027 ($ Million)
Figure 14 Latin America Diagnostic & Monitoring Equipment Market in Corneal Topographers 2019-2027 ($ Million)
Figure 15 Latin America Diagnostic & Monitoring Equipment Market in Other Diagnostic & Monitoring Equipment Market 2019-2027 ($ Million)
Figure 16 Latin America Devices Market in Surgery Device 2019-2027 ($ Million)
Figure 17 Latin America Surgery Devices Market in Cataract Surgery Devices 2019-2027 ($ Million)
Figure 18 Latin America Surgery Devices Market in Glaucoma Surgery Devices 2019-2027 ($ Million)
Figure 19 Latin America Surgery Devices Market in Refractive Surgery Devices 2019-2027 ($ Million)
Figure 20 Latin America Surgery Devices Market in Vitreoretinal Surgery Devices 2019-2027 ($ Million)
Figure 21 Latin America Devices Market in Vision Care Market 2019-2027 ($ Million)
Figure 22 Latin America Drugs and Devices Market in Drugs 2019-2027 ($ Million)
Figure 23 Latin America Drugs Market in Glaucoma Drug 2019-2027 ($ Million)
Figure 24 Latin America Drugs Market in Retinal Disorder Drug 2019-2027 ($ Million)
Figure 25 Latin America Drugs Market in Dry Eye Drug 2019-2027 ($ Million)
Figure 26 Latin America Drugs Market in Allergic Conjunctivitis, Inflammation and Conjunctivitis Drug 2019-2027 ($ Million)
Figure 27 Latin America Drugs by Use of Preservation in Preserved Drugs 2019-2027 ($ Million)
Figure 28 Latin America Drugs by Use of Preservation in Preservation-Free Drugs 2019-2027 ($ Million)
Figure 29 Latin America Preservation-Free Drugs Market in Single-Dose 2019-2027 ($ Million)
Figure 30 Latin America Preservation-Free Drugs Market in Multi-Dose 2019-2027 ($ Million)
Figure 31 Latin America Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 32 Brazil Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 33 Mexico Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Figure 34 Rest of Latin America Countries Ophthalmology Drugs and Devices Market 2019-2027 ($ Million)
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • Allergan, Inc.
  • Bayer
  • Carl Zeiss AG
  • Essilor International S.A.
  • Glaxosmithkline
  • Johnson & Johnson, Inc.
  • Novartis International AG
  • Pfizer
  • Roche Holding AG
  • Santen Pharmaceutical Co., Ltd.
Note: Product cover images may vary from those shown
5 of 4

Loading
LOADING...

Adroll
adroll